tiprankstipranks
Trending News
More News >
bioAffinity Technologies, Inc. (BIAF)
NASDAQ:BIAF
US Market

bioAffinity Technologies, Inc. (BIAF) Income Statement

Compare
168 Followers

bioAffinity Technologies, Inc. Income Statement

Last quarter (Q3 2025), bioAffinity Technologies, Inc.'s total revenue was $1.45M, a decrease of -38.48% from the same quarter last year. In Q3, bioAffinity Technologies, Inc.'s net income was $-5.05M. See bioAffinity Technologies, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.36M$ 2.53M$ 4.80K$ 0.00$ 0.00
Gross Profit
$ 3.38M$ 791.62K$ 4.34K$ -4.82K$ -22.24K
Operating Expenses
$ 12.33M$ 8.77M$ 4.02M$ 2.20M$ 2.58M
Depreciation and Amortization
$ 605.64K$ 249.59K$ 10.18K$ 4.82K$ 22.24K
EBITDA
$ -8.33M$ -7.63M$ -5.61M$ -5.32M$ -6.86M
Operating Income
$ -8.95M$ -7.97M$ -4.01M$ -2.21M$ -2.60M
Other Income/Expenses
$ -75.35K$ 57.21K$ -4.14M$ -4.12M$ -4.66M
Pretax Income
$ -9.03M$ -7.92M$ -8.15M$ -6.32M$ -7.27M
Net Income
$ -9.04M$ -7.94M$ -8.15M$ -6.33M$ -7.27M
Per Share Metrics
Basic EPS
$ -22.50$ -27.30$ -54.30$ -25.80$ -29.70
Diluted EPS
$ -22.50$ -27.30$ -54.30$ -25.80$ -29.70
Weighted Average Shares Outstanding
404.33K 291.60K 149.97K 245.93K 245.93K
Weighted Average Shares Outstanding (Diluted)
404.33K 291.60K 149.97K 245.93K 245.93K
Currency in USD

bioAffinity Technologies, Inc. Earnings and Revenue History